header old site

Aim

The Atlas of Genetics and Cytogenetics in Oncology and Haematology is a peer reviewed on-line journal, encyclopaedia and database in free access on the Internet, devoted to genes, cytogenetics, and clinical entities in cancer, and cancer-prone diseases. The Atlas aims to cover the entire field under study: as the task is huge, the Atlas is -and will be- incomplete by that very fact.

It presents structured reviews (cards) in a portal towards genetics and/or cancer databases and journals, teaching items in Genetics for students in Medicine and in Sciences.

It deals with cancer research and genomics, being at the crossroads of research, virtual medical university (university and post-university e-learning) and telemedicine.

It is made for and by clinicians and researchers in cytogenetics, molecular biologis, oncologists, haematologists, and pathologists.

The Atlas is a not-for-profit organization, in open free access for readers. It relies on individual donations, grants (scientific societies, charities), higher education and health care public institutions.

The Atlas is a collaborative effort!

Historical Survey

In 1997, Jean Loup Huret created the Atlas (someone said "the Wikipedia of Cancer Genetics before Wikipedia"), with Philippe Dessen as the Database Director, who built and maintained the database.

The Atlas contains nearly 3,000 papers and 10,000 pages, written by more than 3,500 authors. Its total content includes 45,000 pages enriched with automatically generated entries (e.g., data on non-annotated genes, developed with Philippe Dessen’s expertise), an iconography of about 35,000 images, 40,000 internal links and 730,000 external links. If printed, it would be about 200,000 pages. It attracts 5,500 unique visitors daily, reflecting its global impact in advancing research.

The Atlas combines different types of knowledge: genes and their function, cell biology, pathological data, diseases and their clinical implications, cytogenetics, but also medical genetics, with hereditary disorders associated with an increased risk of cancer. This gives a wider and more global view of cancer genetics, while these data are usually dispersed. The Atlas is the only genetic site where the prognosis is included. Dr.Dan van Dyke praised it as "This is one stop shopping that unifies cancer genetics information", while Dr.Lidia Larizza described it as that the Atlas was an "interdisciplinary resource". Dr.Felix Mitelman said: -"This systematic collection of cytogenetic and genetic aberrations (…) the molecular outcome (…) and the clinical consequences (….) has grown into a truly monumental encyclopedic work of great importance"; Dr.Janet Rowley said: "In the future I will undoubtedly rely on your Website rather than trying to keep up with the literature myself". It is an original/unique database without an equivalent.

In 2018, the Atlas entered a new phase with the appointment of Paola Dal Cin (Boston, USA) and Jesús M. Hernández Rivas (Salamanca, Spain) as Editors- in-Chief. Under their leadership, the Atlas database was renewed, relocated to Salamanca, and relaunched as Atlas 2.0 in 2022.

The editorial team has since expanded to include Alessandro Beghini (Milano, Italy), Juan Luis García (Salamanca, Spain), and Sheng Xiao (Suzhou, China) as Co-Editors in Chief, reflecting the Atlas’s growing international scope and commitment to advancing cancer genetics and genomics worldwide.

After 25 years of dedicated daily effort building the Atlas day after day, Dr.Jean Loup Huret and Philippe Dessen will take a well-deserved rest and extending their wishes for a long life to the Atlas and to the whole community of clinicians and researchers.

Editorial Board

We would like to express our sincere gratitude to all those who have contributed to this project over the past three years. Their dedication and collaborative effort made it possible to bring Atlas 2.0 to life and ensure its successful launch and growth.


Sections


Solid Tumors
  • Andres Acosta (Indianapolis, USA)
  • Rita Alaggio (Roma, Italy)
  • Judy Bovee (Leiden, The Netherlands)
  • Matteo Fassan (Padova, Italy)
  • Stefano Sioletic (Roma, Italy)
  • Mass General Brigham Pathology teams (Boston, USA):
    • Michelle Hirsch (USA)
    • Jason Hornick (USA)
    • Yen P(rex) Hung (USA)
    • Vicky Jo (USA)
    • Marisa Nucci (USA)
    • David Papke (USA)
    • Carlos. Parra-Herran (USA)
    • Scott Ryall (USA)
    • Inga-Marie Schaeffer (USA)
    • Lynette Sholl (USA)
Haematology
  • Lynne Abruzzo (Charleston, USA.)
  • Sara Alonso (Oviedo, Spain)
  • Ana Battle (Santander, Spain)
  • M Rocío Benito (Salamanca, Spain)
  • Judith Ferry (Boston, USA)
  • Maribel Forero (Tunja, Colombia)
  • Marina Lafage-Pochitaloff (Marseille, France)
  • Cristina Mecucci (Perugia, Italy)
  • Lucienne Michaux (Brussels, Belgium)
  • Marco Antonio Moro (Oviedo, Spain)
  • Liz Pardo (Bogotá, Colombia)
  • Sadeem Qdaisat (Boston, USA)
  • Rocío Salgado (Madrid, Spain)
  • Esperanza Such (Valencia, Spain)
Gene | Cell Biology | Cancer-Prone Diseases
  • Roberto Brusamolino (Monza, Italy)
  • Roberto Cairoli (Milan, Italy)
  • Marta Stefanucci (Milan, Italy)
Asia Coordinators
  • Shiu-Feng Kathy Huang (Taiwan)
  • Zhiheng Li (Suzhou, China)
  • Yulei Shen (Detroit, USA)
  • William Tinge (Suzhou, China)
  • Chunxiao Yang (Suzhou, China)
  • David Zhang (New York, USA)

Acknowledgements

Webpage design and images:

Grants/funding


Association des Cytogénéticiens de Langue Française.
Association de Cytogénétique du Québec
Belgian Society of Human Genetics

Association des Cytogénéticiens de Langue Française.

Association de Cytogénétique du Québec

Belgian Society of Human Genetics